Inhibitors Of Cyclin Dependent Kinases As Anti Tumor Agents


Inhibitors Of Cyclin Dependent Kinases As Anti Tumor Agents
DOWNLOAD

Download Inhibitors Of Cyclin Dependent Kinases As Anti Tumor Agents PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Inhibitors Of Cyclin Dependent Kinases As Anti Tumor Agents book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page





Inhibitors Of Cyclin Dependent Kinases As Anti Tumor Agents


Inhibitors Of Cyclin Dependent Kinases As Anti Tumor Agents
DOWNLOAD

Author : Paul J. Smith
language : en
Publisher: CRC Press
Release Date : 2006-10-25

Inhibitors Of Cyclin Dependent Kinases As Anti Tumor Agents written by Paul J. Smith and has been published by CRC Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2006-10-25 with Medical categories.


One of few books to cover all aspects of cyclin-dependent kinases (CDKs), this volume examines CDKs as molecular and functional entities, their role in various disease processes, and their potential for pharmacological modulation. The book first explains the integration of cell cycle control pathways, opportunities for targeting, targets of inhibitors, and the evaluation of CDK inhibitors. Then it examines the design, development, and chemistry of small molecule CDK inhibitors. The final section assesses the current status of CDK inhibitors in clinical trials, the therapeutic deployment challenges of small molecule inhibitors, and the future prospects of CDK inhibitors as anticancer agents.



Protein Kinase Inhibitors As Sensitizing Agents For Chemotherapy


Protein Kinase Inhibitors As Sensitizing Agents For Chemotherapy
DOWNLOAD

Author :
language : en
Publisher: Academic Press
Release Date : 2018-11-21

Protein Kinase Inhibitors As Sensitizing Agents For Chemotherapy written by and has been published by Academic Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-11-21 with Medical categories.


Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials. Summarizes the sensitizing role of some tyrosine kinase inhibitors in existing research Brings recent findings in several cancer types, both experimental and clinically, with a particular emphases on underlying biochemical, genetic, and molecular mechanisms Provides an updated and comprehensive knowledge regarding the field of combinational cancer treatment



Combination Cancer Therapy


Combination Cancer Therapy
DOWNLOAD

Author : Gary K. Schwartz
language : en
Publisher: Springer Science & Business Media
Release Date : 2007-10-27

Combination Cancer Therapy written by Gary K. Schwartz and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2007-10-27 with Medical categories.


Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future treatments in cancer therapy.



Cyclin Dependent Kinase Cdk Inhibitors


Cyclin Dependent Kinase Cdk Inhibitors
DOWNLOAD

Author : Peter K. Vogt
language : en
Publisher: Springer Science & Business Media
Release Date : 2012-12-06

Cyclin Dependent Kinase Cdk Inhibitors written by Peter K. Vogt and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-12-06 with Medical categories.


More than 10 years ago, the discovery of cyclin-dependent ki nases (Cdks) ushered in a new era in the understanding of cell proliferation and its control. Not only were both of the known cell cycle transitions, from G 1 to S phase and G2 to M phase, found to be dependent on these protein kinases, but the reg ulatory assumption intrinsic to cyclin-dependent kinases, a stable inactive catalytic subunit (the Cdk) and an unstable requisite positive regulatory activating subunit (the cyclin), led to a simple model for cell cycle control. Modulation of cyclin accumulation, and thereby Cdk activation, was proposed to be the overarching principle governing the passage through cell cycle phases. An other reality to emerge from the discovery of Cdks was the ex ceptional degree of evolutionary conservation maintained in the machinery and organization of proliferation control. Not only were Cdks shown to be structurally conserved between yeast and man, but mammalian Cdks could substitute functionally for the endogenous enzymes in a yeast cell. The problem of cell cycle control was thought to have been virtually solved. The ensuing years have provided a much more complex view of cell cycle control and the role and regulation of Cdks. The uncritical enthusiasm with which many of the ideas were em braced has required tempering. For example, although Cdks appear to be highly conserved phylogenetically, cyclins are much less so.



Checkpoint Responses In Cancer Therapy


Checkpoint Responses In Cancer Therapy
DOWNLOAD

Author : Wei Dai
language : en
Publisher: Springer Science & Business Media
Release Date : 2008-05-01

Checkpoint Responses In Cancer Therapy written by Wei Dai and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2008-05-01 with Medical categories.


Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book’s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis.



Cell Cycle Inhibitors In Cancer Therapy


Cell Cycle Inhibitors In Cancer Therapy
DOWNLOAD

Author : Antonio Giordano
language : en
Publisher: Springer Science & Business Media
Release Date : 2002-11-20

Cell Cycle Inhibitors In Cancer Therapy written by Antonio Giordano and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2002-11-20 with Medical categories.


Leading clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell cycle control and demonstrate its clinical relevance to understanding neoplastic diseases. Topics range from Cdk inhibitors and cell cycle regulators to the prognostic value of p27 and tumor suppressor genes as diagnostic tools. Actual case studies show how the new molecular understanding has produced such drugs as Flavopiridol and Sulindac. The book brings all the recent critical research findings to bear on clinical practice, and clearly shows their powerful impact on the diagnostics, prognostics, and therapeutics of cancer, AIDS, and cardiovascular disease.



Resistance To Anti Cancer Therapeutics Targeting Receptor Tyrosine Kinases And Downstream Pathways


Resistance To Anti Cancer Therapeutics Targeting Receptor Tyrosine Kinases And Downstream Pathways
DOWNLOAD

Author : Yosef Yarden
language : en
Publisher: Springer
Release Date : 2018-03-28

Resistance To Anti Cancer Therapeutics Targeting Receptor Tyrosine Kinases And Downstream Pathways written by Yosef Yarden and has been published by Springer this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-03-28 with Medical categories.


This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.



Advances In Cancer Drug Targets


Advances In Cancer Drug Targets
DOWNLOAD

Author : Atta-ur-Rahman
language : en
Publisher: Bentham Science Publishers
Release Date : 2013-01-18

Advances In Cancer Drug Targets written by Atta-ur-Rahman and has been published by Bentham Science Publishers this book supported file pdf, txt, epub, kindle and other format this book has been release on 2013-01-18 with Medical categories.


Advances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA. The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists.



Therapeutic Potential Of Cell Cycle Kinases In Breast Cancer


Therapeutic Potential Of Cell Cycle Kinases In Breast Cancer
DOWNLOAD

Author : Manzoor Mir
language : en
Publisher: Springer Nature
Release Date : 2023-03-03

Therapeutic Potential Of Cell Cycle Kinases In Breast Cancer written by Manzoor Mir and has been published by Springer Nature this book supported file pdf, txt, epub, kindle and other format this book has been release on 2023-03-03 with Medical categories.


This book highlights the interrelation between cell cycle regulators and breast cancer phenotypes. It reviews the roles of Cyclin-Dependent Kinases (CDK) in driving cell cycle progression, cell cycle checkpoints and dysregulation in breast cancer. It also examines the prognostic significance of CDKs in breast cancer. and CDK inhibitors for the treatment of metastatic breast cancer. Further, the book discusses the role of different G1 cyclins in differentiation, chromosome stability, and transcriptional regulation in breast cancer. Additionally, it examines the role of immunogenic effects of CDK inhibitors, the mechanism of resistance and the current clinical trials in breast cancer treatment. Towards the end, the book explores cell cycle regulation as an attractive target for targeted drug therapy in breast cancer. This book is a comprehensive yet concise resource for oncologists and researchers interested in exploring the therapeutic potential of Cyclin-Dependent Kinases in breast cancer. ​



Natural Products For Cancer Chemoprevention


Natural Products For Cancer Chemoprevention
DOWNLOAD

Author : John M. Pezzuto
language : en
Publisher: Springer Nature
Release Date : 2020-04-03

Natural Products For Cancer Chemoprevention written by John M. Pezzuto and has been published by Springer Nature this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-04-03 with Medical categories.


This book discusses the efficacy of various naturally occurring chemopreventive agents in preventing or delaying cancer. It focuses on the holistic chemopreventive concept, demonstrating the relevant response is the combined effect of a series of compounds that alone have been shown to have some effect in different experimental models. Written by leading experts in the field, the contributions provide details of research on various chemopreventive agents. Offering insights into the unique molecular targets and mechanisms, safety issues, molecular efficacy, and occurrence in nature of these compounds, the book is a valuable resource for all scientists working in biomedicine, and specifically in cancer research.